Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimal Initial Therapy (MIT) for "Early" Supradiaphragmatic Hodgkin's Disease: A Multicenter Randomized Trial of Short Neoadjuvant Chemotherapy (VAPEC-B) Plus Involved Field Radiotherapy (MIT) Versus Mantle Radiotherapy

NCT00002987 is registered in ClinicalTrials.gov with Medical Research Council as lead sponsor.

NCT NCT00002987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimal Initial Therapy (MIT) for "Early" Supradiaphragmatic Hodgkin's Disease: A Multicenter Randomized Trial of Short Neoadjuvant Chemotherapy (VAPEC-B) Plus Involved Field Radiotherapy (MIT) Versus Mantle Radiotherapy
Lead sponsor
Medical Research Council
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 1997
Completion date
Not reported
Enrollment
400 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma